| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $3,567,776 | 37 | 100 |
| Wuchterl Donald A. | director | 0 | $0 | 1 | $75,412 | $-75,412 |
| Alland Leila | director | 0 | $0 | 2 | $157,049 | $-157,049 |
| Silverstein Christine Berni | director | 0 | $0 | 2 | $205,864 | $-205,864 |
| Crombez Eric | director | 0 | $0 | 2 | $227,531 | $-227,531 |
| O'Malley Brendan M. | SVP, Chief Legal Officer | 0 | $0 | 5 | $250,623 | $-250,623 |
| Vasanthavada Madhav | Chief Commercial Officer | 0 | $0 | 6 | $264,337 | $-264,337 |
| Alvino Mark | director | 0 | $0 | 5 | $275,351 | $-275,351 |
| Vazzano Joseph Walter | Chief Financial Officer | 0 | $0 | 7 | $598,779 | $-598,779 |
| Seshadri Vishwas | Chief Executive Officer | 0 | $0 | 7 | $1.51M | $-1.51M |
Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epidermolysis bullosa. The company's pipeline also features several other promising therapies: ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A. ABO-201, intended …
Over the last 12 months, insiders at Abeona Therapeutics Inc. have bought $0 and sold $3.57M worth of Abeona Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Abeona Therapeutics Inc. have bought $202,195 and sold $1.23M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 11,000 shares for transaction amount of $51,799 was made by Alland Leila (director) on 2024‑05‑16.
| 2026-09-29 | Sale | Seshadri Vishwas | Chief Executive Officer | 19,608 0.0344% | $5.16 | $101,091 | -11.82% | |
| 2026-09-29 | Sale | Vazzano Joseph Walter | Chief Financial Officer | 9,191 0.0161% | $5.16 | $47,385 | -11.82% | |
| 2026-09-29 | Sale | O'Malley Brendan M. | SVP, Chief Legal Officer | 6,727 0.0118% | $5.16 | $34,682 | -11.82% | |
| 2026-09-29 | Sale | Vasanthavada Madhav | Chief Commercial Officer | 4,902 0.0086% | $5.16 | $25,273 | -11.82% | |
| 2026-09-01 | Sale | Alvino Mark | director | 15,000 0.0258% | $5.86 | $87,966 | -15.47% | |
| 2026-07-21 | Sale | Vazzano Joseph Walter | Chief Financial Officer | 1,478 0.0026% | $6.53 | $9,651 | -13.78% | |
| 2026-07-09 | Sale | Seshadri Vishwas | Chief Executive Officer | 67,971 0.1221% | $6.96 | $473,330 | -17.84% | |
| 2026-07-09 | Sale | Vazzano Joseph Walter | Chief Financial Officer | 24,880 0.0447% | $6.96 | $173,257 | -17.84% | |
| 2026-07-09 | Sale | O'Malley Brendan M. | SVP, Chief Legal Officer | 12,050 0.0217% | $6.96 | $83,913 | -17.84% | |
| 2026-07-09 | Sale | Vasanthavada Madhav | Chief Commercial Officer | 12,606 0.0227% | $6.96 | $87,784 | -17.84% | |
| 2026-06-30 | Sale | Alland Leila | director | 11,000 0.0185% | $5.92 | $65,087 | -3.96% | |
| 2026-06-15 | Sale | Silverstein Christine Berni | director | 18,160 0.0329% | $5.71 | $103,695 | +2.91% | |
| 2026-06-09 | Sale | Seshadri Vishwas | Chief Executive Officer | 31,916 0.0552% | $5.30 | $169,289 | +6.05% | |
| 2026-06-09 | Sale | Vazzano Joseph Walter | Chief Financial Officer | 39,067 0.0683% | $5.36 | $209,476 | +6.05% | |
| 2026-06-09 | Sale | O'Malley Brendan M. | SVP, Chief Legal Officer | 6,305 0.0109% | $5.30 | $33,443 | +6.05% | |
| 2026-06-09 | Sale | Vasanthavada Madhav | Chief Commercial Officer | 5,450 0.0094% | $5.30 | $28,908 | +6.05% | |
| 2026-06-08 | Sale | Seshadri Vishwas | Chief Executive Officer | 24,428 0.0433% | $5.43 | $132,632 | +7.25% | |
| 2026-06-08 | Sale | Vazzano Joseph Walter | Chief Financial Officer | 10,271 0.0182% | $5.43 | $55,766 | +7.25% | |
| 2026-06-08 | Sale | O'Malley Brendan M. | SVP, Chief Legal Officer | 4,826 0.0085% | $5.43 | $26,203 | +7.25% | |
| 2026-06-08 | Sale | Vasanthavada Madhav | Chief Commercial Officer | 4,170 0.0074% | $5.43 | $22,641 | +7.25% |
| Seshadri Vishwas | Chief Executive Officer | 1286500 2.2498% | $5.47M | 3 | 13 | +40.3% |
| Vazzano Joseph Walter | Chief Financial Officer | 482888 0.8444% | $2.05M | 3 | 12 | +24.48% |
| O'Malley Brendan M. | SVP, Chief Legal Officer | 421226 0.7366% | $1.79M | 4 | 14 | +20.67% |
| Alland Leila | director | 162614 0.2844% | $691,109.50 | 1 | 3 | +18.59% |
| Ahn Mark J | director | 343182 0.6001% | $1.46M | 2 | 0 | <0.0001% |
| Rouhandeh Steven H | 315042 0.5509% | $1.34M | 1 | 0 | +20.49% | |
| FEINBERG LARRY N | 10 percent owner | 296483 0.5185% | $1.26M | 5 | 11 | |
| Buono Stefano | director | 270000 0.4722% | $1.15M | 3 | 0 | <0.0001% |
| GRAY KERRY P | President and CEO | 183340 0.3206% | $779,195.00 | 2 | 0 | |
| Charles Faith L. | director | 139094 0.2432% | $591,149.50 | 1 | 2 | +63.5% |
| Howell Stephen B. | director | 79494 0.139% | $337,849.50 | 1 | 0 | <0.0001% |
| Jeffrey B Davis | director | 67858 0.1187% | $288,396.50 | 1 | 0 | +20.49% |
| NOWOTNIK DAVID P | Sr Vice President R&D | 62000 0.1084% | $263,500.00 | 1 | 0 | |
| Meakem John J | director | 45000 0.0787% | $191,250.00 | 3 | 0 | |
| Van Duyne Richard B | director | 6000 0.0105% | $25,500.00 | 1 | 0 | <0.0001% |
| Wider Todd | director | 0 0% | $0 | 2 | 8 | <0.0001% |
$6,146,922 | 96 | -4.70% | $233.68M | |
$60,836,085 | 69 | 0.45% | $255.44M | |
$19,239,249 | 50 | -2.24% | $238.33M | |
$109,019,806 | 28 | 7.37% | $263.86M | |
Abeona Therapeutics Inc. (ABEO) | $3,668,031 | 23 | 2.05% | $243.03M |
| Increased Positions | 59 | +53.64% | 11M | +32.32% |
| Decreased Positions | 48 | -43.64% | 8M | -22.9% |
| New Positions | 22 | New | 6M | New |
| Sold Out Positions | 18 | Sold Out | 6M | Sold Out |
| Total Postitions | 121 | +10% | 39M | +9.42% |
| Nantahala Capital Management, Llc | $24,238.00 | 8.45% | 4.56M | +195,000 | +4.46% | 2025-09-30 |
| Blackrock, Inc. | $16,711.00 | 5.83% | 3.15M | +147,996 | +4.93% | 2025-09-30 |
| Adage Capital Partners Gp, L.L.C. | $16,185.00 | 5.64% | 3.05M | -25,000 | -0.81% | 2025-09-30 |
| Suvretta Capital Management, Llc | $14,210.00 | 4.96% | 2.68M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $13,821.00 | 4.82% | 2.6M | +95,878 | +3.82% | 2025-09-30 |
| Vivo Capital, Llc | $9,785.00 | 3.41% | 1.84M | 0 | 0% | 2025-09-30 |
| Western Standard Llc | $6,637.00 | 2.32% | 1.25M | -841,641 | -40.24% | 2025-09-30 |
| Geode Capital Management, Llc | $5,985.00 | 2.09% | 1.13M | +21,269 | +1.92% | 2025-09-30 |
| Kennedy Capital Management Llc | $5,580.00 | 1.95% | 1.05M | +378,860 | +56.38% | 2025-09-30 |
| Silverarc Capital Management, Llc | $5,282.00 | 1.84% | 994,754 | +76,856 | +8.37% | 2025-09-30 |